[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Patient Information Sheet
Escitalopram oxalate (marketed as Lexapro)

This is a summary of the most important information about Lexapro. For details, talk to your healthcare professional.


FDA ALERT [07/2006] – Possible Life- Threatening Serotonin Syndrome When Used With Triptan Medicines

A life-threatening condition called serotonin syndrome can happen when medicines called selective serotonin reuptake inhibitors (SSRIs), such as Lexapro, and medicines used to treat migraine headaches known as 5-hydroxytryptamine receptor agonists (triptans), are used together.  Signs and symptoms of serotonin syndrome include the following:

  • restlessness
  • hallucinations
  • loss of coordination
  • fast heart beat
  • increased body temperature
  • fast changes in blood pressure
  • overactive reflexes
  • diarrhea
  • coma
  • nausea
  • vomiting

Serotonin syndrome may be more likely to occur when starting or increasing the dose of an SSRI or a triptan.  This information comes from reports sent to FDA and knowledge of how these medicines work.  If you take migraine headache medicines, ask your healthcare professional if your medicine is a triptan.

Before you take Lexapro and a triptan together, talk to your healthcare professional.  If you must take these medicines together, be aware of the possibility of serotonin syndrome, and get medical care right away if you think serotonin syndrome is happening to you. 

This information reflects FDA’s current analysis of data available to FDA concerning this drug. FDA intends to update this sheet when additional information or analyses become available.


FDA ALERT [07/2006] – Infant Persistent Pulmonary Hypertension
The results of a study that looked at the use of antidepressant medicines during pregnancy in  mothers of babies born with a serious condition called persistent pulmonary hypertension of the newborn (PPHN) were recently published in a medical journal.
Babies born with PPHN have abnormal blood flow through the heart and lungs and do not get enough oxygen to their bodies.  Babies with PPHN can be very sick and may die. 

The study results showed that:

  • babies born to mothers who took selective serotonin reuptake inhibitors (SSRIs), the family of medicines Luvox belongs to,
  • 20 weeks or later in their pregnancies,
  • had a higher chance (were 6 times as likely) to have persistent pulmonary hypertension (PPHN),
  • than babies born to mothers who did not take antidepressants during pregnancy.

The FDA plans to further look at the role of SSRIs in babies with PPHN.
Talk to your doctor if you are taking lexapro and are pregnant or are planning to have a baby.  You and your doctor will need to talk about the best way to treat your depression during pregnancy.

This information reflects FDA’s current analysis of data available to FDA concerning this drug. FDA intends to update this sheet when additional information or analyses become available.


What is Lexapro?

Lexapro is in a class of medicines called selective serotonin reuptake inhibitors (SSRIs).

Lexapro tablets and oral solution are used to treat:

  • Depression
  • Generalized Anxiety Disorder (GAD)

Who Should Not Take Lexapro?
Never take Lexapro if you are taking another drug used to treat depression, called a Monoamine Oxidase Inhibitor (MAOI), or if you have stopped taking an MAOI in the last 14 days. Taking Lexapro close in time to an MAOI can result in serious, sometimes fatal, reactions, including:

  • High body temperature
  • Coma
  • Seizures (convulsions)

MAOI drugs include Nardil (phenelzine sulfate), Parnate (tranylcypromine sulfate), Marplan (isocarboxazid), and other brands.

What Are The Risks?

The following are the major potential risks and side effects of Lexapro therapy.  However, this list is not complete.

  • Possible life-threatening serotonin syndrome when used with triptan medicines:  See FDA Alert [07/2006] above.

  • Infant persistent pulmonary hypertension:  See FDA Alert [07/2006] above.

  • Suicidal thoughts or actions: Persons taking Lexapro may be more likely to think about killing themselves or actually try to do so, especially when Lexapro is first started or the dose is changed.  People close to persons taking Lexapro can help by paying attention to changes in user’s moods or actions.   Contact your healthcare professional right away if someone using Lexapro talks about or shows signs of killing him or herself.  If you are taking Lexapro yourself and you start thinking about killing yourself, tell your healthcare professional about this side effect right away.

  • Stopping Lexapro: Do not stop taking Lexapro suddenly because you could get side effects. Your healthcare professional will slowly decrease your dose.

  • Bleeding problems: Lexapro may cause bleeding problems, especially if taken with aspirin, NSAIDs (nonsteroidal anti-inflammatory drugs, such as ibuprofen and naproxen), or other drugs that affect bleeding.

  • Mania: You may become unusually hyperactive, excitable or elated.

  • Seizures: You may experience a seizure (convulsion), even if you are not taking Lexapro close in time with an MAOI.

  • Pregnancy: Tell your healthcare professional if you are or may be pregnant (see FDA Alert [07/2006] above).  In addition to the issue described in the alert,  babies delivered to mothers taking Lexapro late in pregnancy have developed problems, such as difficulty breathing and feeding.

  • Sexual problems: You may have problems with impotence (erectile dysfunction), abnormal ejaculation, difficulty reaching orgasm, or decreased libido (sexual desire).

  • Other side effects include difficulty sleeping, nausea, increased sweating, fatigue, and sleepiness.

  • Tell your healthcare professional about all your medical conditions, especially liver or kidney disease. Tell your healthcare professional if you are breast-feeding or plan to breast-feed your baby.

Are There Any Interactions With Drugs or Foods?

  • Do not take Lexapro with Celexa (citalopram), another drug used to treat depression, because they are very similar and you could get an overdose.

  • Lexapro may interact with medicines other than the ones already mentioned in this information sheet. These interactions can cause serious side effects. Tell your healthcare professional about all medicines, vitamins, and herbal supplements you take.

  • If you plan to drink alcohol, talk to your healthcare professional.

How Do I Take Lexapro?

Lexapro is taken by mouth, with or without food, exactly as prescribed by your healthcare professional.

Is There Anything Else I need to Know?

You can get more information about antidepressants at:  http://www.fda.gov/cder/drug/antidepressants/default.htm

Date this drug approved 2002
Patient Information Sheet Revised 07/2005
Patient Information Sheet Revised 07/2006

Questions? Call Drug Information, 1-888-INFO-FDA (automated) or 301-827-4570
druginfo@fda.hhs.gov

Back to Top     Back to Escitalopram

Date created: May 2005; Updated: July 19, 2006

horizonal rule